AbCellera Biologics Inc. (ABCL) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

AbCellera Biologics Inc.

NASDAQ: ABCL · Real-Time Price · USD
4.22
0.06 (1.44%)
At close: Sep 05, 2025, 3:59 PM
4.22
0.00%
After-hours: Sep 05, 2025, 07:08 PM EDT

AbCellera Biologics Revenue

AbCellera Biologics reported an annual revenue of $28.83M, reflecting a -24.17% growth. For the quarter ending June 30, 2025, AbCellera Biologics generated $17.08M in revenue.
Revenue (ttm)
28.83M
Revenue Growth
-24.17%
Price / Sales Ratio
29.91
Revenue / Employee
48.38K
Employees
596
Market Cap
1.26B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 28.83M -24.17%
Dec 31, 2023 38.02M -92.17%
Dec 31, 2022 485.42M +29.38%
Dec 31, 2021 375.2M +60.92%
Dec 31, 2020 233.16M +1907.96%
Dec 31, 2019 11.61M +31.49%
Dec 31, 2018 8.83M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.